Rakesh Tripathi

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

Mark Sulkowski, Joseph J. Eron, David Wyles et al. · JAMA · 2015 · 305 citations · Full text

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

Fred Poordad, Eric Lawitz, Kris V. Kowdley et al. · New England Journal of Medicine · 2013 · 285 citations · Full text

Use of a Fluorescence Plate Reader for Measuring Kinetic Parameters with Inner Filter Effect Correction

Yaya Liu, Warren M. Kati, Chih‐Ming Chen et al. · Analytical Biochemistry · 1999 · 204 citations

Engineering, Biomedical Imaging, Fluorescence Plate Reader +8

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Teresa I. Ng, Preethi Krishnan, Warren M. Kati et al. · Antimicrobial Agents and Chemotherapy · 2017 · 136 citations · Full text

<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450

Rakesh Tripathi, Daniel E. Cohen, I. Gaultier et al. · Antimicrobial Agents and Chemotherapy · 2014 · 116 citations · Full text

Cytochrome P450 3A4, Viral Hepatitis, Medicine +13